• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 再感染/再激活病例的临床表现。

Clinical Presentation of Cases with SARS-CoV-2 Reinfection/ Reactivation.

机构信息

Department of Obstetrics and Gynecology Topiwala National Medical College and BYL Nair Charitable Hospital, Mumbai, Maharashtra.

ICMR-National Institute for Research in Reproductive Health, Mumbai.

出版信息

J Assoc Physicians India. 2021 Jan;69(1):16-18.

PMID:34227769
Abstract

BACKGROUND

Reinfection/reactivation of SARS-CoV-2 has been a matter of great interest from the immunological and vaccine perspective. However, little is known about the clinical presentation of such reinfection/reactivation. We report a case series of 9 COVID-19 patients having experienced two clinically- and/or virologically-confirmed episodes of COVID-19.

METHODS

Epidemiological and clinical characteristics of 9 healthcare workers (HCWs) with two episodes of SARS-CoV-2 are described.

RESULTS

The incidence of reinfection/reactivation amongst the HCWs was 2% (9 out of 491) with an average remission period of 66 days (range 43-78 days). Amongst the cases of reinfection 4/9 were asymptomatic in first episode were symptomatic in second episode. There is negative correlation between numbers of days the patients took to become SARS-CoV-2 negative by RT-CPR and/or clinically recover in the first episode and the second episode irrespective for the time spent in remission.

CONCLUSION

Shorter durations of SARS-COV-2 infection in the first episode are associated with longer time to recovery in the second episode in patients with re-infection/reactivation.

摘要

背景

从免疫学和疫苗角度来看,SARS-CoV-2 的再感染/再激活一直是人们关注的焦点。然而,对于这种再感染/再激活的临床表现知之甚少。我们报告了 9 例 COVID-19 患者经历了两次临床和/或病毒学确诊的 COVID-19 发作的病例系列。

方法

描述了 9 名有两期 SARS-CoV-2 发作的医护人员的流行病学和临床特征。

结果

医护人员的再感染/再激活发生率为 2%(491 人中有 9 人),平均缓解期为 66 天(范围为 43-78 天)。在再感染病例中,有 4/9 人在第一次发作时无症状,第二次发作时出现症状。第一次发作中患者通过 RT-PCR 和/或临床恢复为 SARS-CoV-2 阴性的天数与第二次发作中恢复的天数之间存在负相关,而与缓解期的时间无关。

结论

在再感染/再激活患者中,第一次 SARS-COV-2 感染的持续时间越短,第二次发作的恢复时间就越长。

相似文献

1
Clinical Presentation of Cases with SARS-CoV-2 Reinfection/ Reactivation.SARS-CoV-2 再感染/再激活病例的临床表现。
J Assoc Physicians India. 2021 Jan;69(1):16-18.
2
SARS-CoV-2 Reinfection among Healthcare Workers in Mexico: Case Report and Literature Review.墨西哥医护人员中再次感染 SARS-CoV-2:病例报告和文献回顾。
Medicina (Kaunas). 2021 May 3;57(5):442. doi: 10.3390/medicina57050442.
3
Reinfection of SARS-CoV-2 - analysis of 23 cases from the literature.SARS-CoV-2 再感染 - 文献中 23 例分析。
Infect Dis (Lond). 2021 Jul;53(7):479-485. doi: 10.1080/23744235.2021.1905174. Epub 2021 Apr 13.
4
SARS-CoV-2 reinfection and COVID-19 severity.SARS-CoV-2 再感染与 COVID-19 严重程度。
Emerg Microbes Infect. 2022 Dec;11(1):894-901. doi: 10.1080/22221751.2022.2052358.
5
High Post-Infection Protection after COVID-19 among Healthcare Workers: A Population-Level Observational Study.新冠病毒感染后对医护人员的高保护作用:一项基于人群的观察性研究。
Iran J Med Sci. 2024 Apr 1;49(4):247-258. doi: 10.30476/IJMS.2023.97708.2951. eCollection 2024 Apr.
6
No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris.在巴黎第一波和第二波疫情期间,对医护人员进行全院范围的前瞻性筛查,未发现有 SARS-CoV-2 再感染病例。
J Clin Virol. 2021 Dec;145:104999. doi: 10.1016/j.jcv.2021.104999. Epub 2021 Oct 19.
7
Symptomatic SARS-COV-2 reinfection: healthcare workers and immunosuppressed individuals at high risk.有症状的 SARS-CoV-2 再感染:医护人员和免疫抑制个体为高危人群。
BMC Infect Dis. 2021 Sep 6;21(1):923. doi: 10.1186/s12879-021-06643-1.
8
A retrospective cross-sectional observational study of SARS-CoV-2 reinfection in La Ribera Health Department, Valencia, Spain.西班牙瓦伦西亚拉利贝拉卫生局关于 SARS-CoV-2 再感染的回顾性横断面观察性研究。
J Med Microbiol. 2022 Oct;71(10). doi: 10.1099/jmm.0.001599.
9
Clinical characteristics of SARS-CoV-2 by re-infection vs. reactivation: a case series from Iran.再感染与再激活的 SARS-CoV-2 的临床特征:来自伊朗的病例系列。
Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1713-1719. doi: 10.1007/s10096-021-04221-6. Epub 2021 Mar 18.
10
Possible Cases of SARS-CoV-2 Reinfection In Pekanbaru, Indonesia.印度尼西亚北干巴鲁可能的 SARS-CoV-2 再感染病例。
Acta Med Indones. 2022 Jan;54(1):107-113.

引用本文的文献

1
Reinfection of COVID-19 among doctors at a tertiary care centre in Northern India: A report from a resource-limited setting.印度北部一家三级医疗中心医生中新冠病毒再次感染情况:来自资源有限环境的报告。
Lung India. 2023 Mar-Apr;40(2):123-127. doi: 10.4103/lungindia.lungindia_261_22.
2
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.SARS-CoV-2 再感染在保加利亚前三次 COVID-19 大流行期间。
PLoS One. 2022 Sep 9;17(9):e0274509. doi: 10.1371/journal.pone.0274509. eCollection 2022.
3
SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature.
SARS-CoV-2 再次感染对全球疫苗接种运动的效果构成新挑战:对文献报告病例的系统评价。
Int J Environ Res Public Health. 2021 Oct 19;18(20):11001. doi: 10.3390/ijerph182011001.